Ellomay Capital Reports Results for the Three Months Ended March 31, 2022

<br /> Ellomay Capital Reports Results for the Three Months Ended March 31, 2022<br />

PR Newswire



TEL AVIV, Israel


,


June 29, 2022


/PRNewswire/ —

Ellomay Capital Ltd.

(NYSE American: ELLO) (TASE: ELLO)

(“Ellomay” or the “Company”)

, a renewable energy and power generator and developer of renewable energy and power projects in

Europe

and Israel, today reported unaudited financial results for the three month period ended

March 31, 2022

.


Financial Highlights

  • Revenues were approximately €11.8 million for the three months ended

    March 31, 2022

    , compared to approximately €7.2 million for the three months ended

    March 31, 2021

    . This increase mainly results from the substantial increase in electricity prices in

    Europe

    since the commencement of the military conflict between

    Russia

    and

    Ukraine

    and the Company recognizing revenues from the Talasol photovoltaic facility (the ”

    Talasol PV Plant

    “) for the entire first quarter of 2022, compared to recognition of revenues from the Talasol PV Plant for a portion of the first quarter of 2021, commencing upon the achievement of PAC (Preliminary Acceptance Certificate) by the Talasol PV Plant on

    January 27, 2021

    .
  • Operating expenses were approximately €6 million for the three months ended

    March 31, 2022

    , compared to approximately €3.2 million for the three months ended

    March 31, 2021

    . Depreciation expenses were approximately €4 million for the three months ended

    March 31, 2022

    , compared to approximately €3.1 million for the three months ended

    March 31, 2021

    . The increase in operating expenses mainly results from the introduction of the Spanish RDL 17/2021 that establishes the reduction, until

    June 30, 2022

    , of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. The increase in operating expenses and depreciation expenses is also attributable to the recognition of results of the Talasol PV Plant for the entire first quarter of 2022, compared to a partial recognition (commencing upon the achievement of PAC of the Talasol PV Plant on

    January 27, 2021

    ) for the first quarter of 2021.
  • Project development costs were approximately €0.7 million for the three months ended

    March 31, 2022

    , compared to approximately €0.5 million for the three months ended

    March 31, 2021

    . The increase in project development costs is mainly due to the development of photovoltaic projects in

    Italy

    and

    Spain

    .
  • General and administrative expenses were approximately €1.5 million for the three months ended

    March 31, 2022

    , compared to approximately €1.3 million for the three months ended

    March 31, 2021

    . There was no material change in the composition of the expenses included in general and administrative expenses between the two periods.
  • Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €0.2 million for the three months ended

    March 31, 2022

    , compared to approximately €0.6 million for the three months ended

    March 31, 2021

    . The decrease in the Company’s share of profit of equity accounted investee is mainly attributable to higher financing expenses incurred by Dorad for the period as a result of the CPI indexation of loans from banks.
  • Financing expenses, net were approximately €2.9 million for the three months ended

    March 31, 2022

    , compared to approximately €2.8 million for the three months ended

    March 31, 2021

    . The increase in financing expenses, net, was mainly attributable to financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC, interest and linkage differences in connection with an agreement entered into with the Israeli Tax Authority in connection with a final assessment agreement for the years 2015-2020 of the Talmei Yosef PV Plant, partially offset by a decrease in financing expenses compared to the first quarter of 2021, during which the Company recognized expenses amounting to approximately €0.8 million in connection with the early repayment of the Company’s Series B Debentures.
  • Taxes on income were approximately €0.3 million for the three months ended

    March 31, 2022

    , compared to tax benefits of approximately €0.3 million for the three months ended

    March 31, 2021

    .
  • Loss for the three months ended

    March 31, 2022

    was approximately €3.4 million, compared to a loss of approximately €2.7 million for the three months ended

    March 31, 2021

    .
  • Total other comprehensive loss was approximately €40.9 million for the three months ended

    March 31, 2022

    , compared to approximately €2.4 million for the three months ended

    March 31, 2021

    . The increase in total other comprehensive loss mainly resulted from changes in fair value of cash flow hedges, including a material reduction in the fair value of the financial power swap (the ”

    PPA

    “) that covers approximately 80% of the output of the Talasol PV Plant. The PPA experienced a high volatility due to the substantial increase in electricity prices in

    Europe

    since the commencement of the military conflict between

    Russia

    and

    Ukraine

    . In accordance with hedge accounting standards, the changes in the PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows. As the Company controls Talasol, the total impact of the changes in fair value of the PPA (including the minority share) is consolidated into the Company’s financial statements and total equity. Alongside the decrease in fair value of the PPA, the increase in the electricity prices is expected to have a positive impact on Talasol’s revenues from the sale of the capacity that is not subject to the PPA, resulting in an expected increase in Talasol’s net income and cash flows.
  • Total comprehensive loss was approximately €44.2 million for the three months ended

    March 31, 2022

    , compared to approximately €5 million for the three months ended

    March 31, 2021

    .
  • EBITDA was approximately €3.8 million for the three months ended

    March 31, 2022

    , compared to approximately €2.9 million for the three months ended

    March 31, 2021

    . See the table on page 12 of this press release for a reconciliation of these numbers to profit and loss.
  • Net cash provided by operating activities was approximately €8.1 million for the three months ended

    March 31, 2022

    , compared to approximately €1.3 million for the three months ended

    March 31, 2021

    . The increase is mainly attributable to the recognition of results of the Talasol PV Plant for the entire first quarter of 2022, compared to a partial recognition (commencing upon the achievement of PAC of the Talasol PV Plant on

    January 27, 2021

    ) for the first quarter of 2021.



CEO Review – First Quarter of 2022

The first quarter of 2022 represents an increase in revenues of approximately 60% compared to the first quarter of 2021.

As a result of the war in

Ukraine

and the gas shortage, the electricity prices in

Europe

increased threefold compared to last year. The increase in electricity prices had a positive impact on the Company’s revenues and is the main reason for the increase in revenues.

Talasol currently sells approximately 75% of the electricity produced by its PV facility under a long-term electricity purchase agreement (the ”

PPA

” or the ”

Derivative

“), therefore the increase in revenues is based mainly on the electricity that is not sold under the PPA.

As a result of the increase in electricity prices in

Europe

(which generally benefited the Company) the fair value of the Derivative decreased by approximately €60 million as of

March 31, 2022

.

As the Derivative is a non-speculative hedge, the change in its fair value does not impact the Company’s cash flows or net profit, and the entire decrease in fair value is recorded through a hedging reserve. The impact of the change is a decrease in the Company’s consolidated equity. Upon expiration of the Derivative (in approximately 8.5 years), the value of the Derivative is recorded as zero.

During the first quarter of 2022, Talasol refinanced its loans. The new financing is based on the Derivative and was therefore provided on very convenient terms: a fixed average annual interest of approximately 3% in euro, a term of approximately 23 years, and a leverage of approximately 75% of the cost of construction of the project.

This financing significantly improved the cash flow to the shareholders of Talasol, including the Company (which indirectly owns 51% of Talasol), and increased the return to Talasol’s shareholders to approximately 14%, without taking into account the current electricity prices that are expected to further improve the return to Talasol’s shareholders.

During the first quarter of 2022, the construction of the Ellomay Solar project in

Spain

(28 MW PV) was completed. This project was connected to the electricity grid during the second quarter of 2022. The electricity of this project is sold in market prices and the project was constructed without outside financing (“full equity”). The Company is planning to examine several proposals to finance this project.

The construction of the first project in

Italy

(20 MW PV) commenced during the second quarter of 2022. Out of the projects under development, to date building permits were issued for an additional 102 MW and these are undergoing contractors’ tender processes. An additional approximately 430 MW are under advanced development stages.

The biogas operations in

the Netherlands

was impacted by the war in

Ukraine

causing shortages in certain raw materials and an increase in delivery prices. As of today the supply of raw materials has been renewed and the increase in prices is compensated by the increase in prices of the green certificates. The European Union and the Dutch government set a high manufacturing target for the biogas industry as part of the reduction of the dependency on

Russia

and a plan to support this industry is expected to be published shortly.

The construction of the pumped storage project in the Manara Cliff in

Israel

is advancing as planned. The main access tunnel reached more than 200 meter depth in the mountain and extensive excavation works are performed in the upper reservoir and in the low pressure tunnel in the area of the bottom reservoir.

The Company projects  that it will record revenues of approximately €16 million in the second quarter of 2022.


Use of NON-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 12 of this press release.


About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in

Europe

and

Israel

.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in

Israel

,

Italy

and

Spain

, including:

  • Approximately 35.9 MW of photovoltaic power plants in

    Spain

    and a photovoltaic power plant of approximately 9 MW in

    Israel

    ;
  • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of

    Israel’s

    largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of

    Israel’s

    total current electricity consumption;
  • 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres,

    Spain

    ;
  • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the

    Netherlands

    , with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
  • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff,

    Israel

    .

For more information about Ellomay, visit

http://www.ellomay.com

.


Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including the impact of continued war between

Russia

and

Ukraine

, including its impact on electricity prices, availability of raw materials and disruptions in supply changes, the impact of the Covid-19 pandemic on the Company’s operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in

Spain

, increases in interest rates, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.


Contact:


Kalia Rubenbach (Weintraub)

CFO

Tel: +972 (3) 797-1111

Email:

[email protected]


Ellomay Capital Ltd. and its Subsidiaries



Condensed Consolidated Interim Statements of Financial Position



March 31,



December 31,



March 31,



2022



2021



2022



Unaudited



Audited



Unaudited



€ in thousands



Convenience Translation into

US$ in thousands*



Assets



Current assets:


Cash and cash equivalents



90,981


41,229



100,938


Marketable securities



1,833


1,946



2,034


Short term deposits



28,380


28,410



31,486


Restricted cash



1,000


1,000



1,109


Receivable from concession project



1,776


1,784



1,970


Trade and other receivables



12,088


9,487



13,411



136,058


83,856



150,948



Non-current assets


Investment in equity accounted investee



34,255


34,029



38,004


Advances on account of investments



1,554


1,554



1,724


Receivable from concession project



26,959


26,909



29,910


Fixed assets



351,305


340,065



389,754


Right-of-use asset



23,027


23,367



25,547


Intangible asset



4,658


4,762



5,168


Restricted cash and deposits



14,521


15,630



16,110


Deferred tax



26,728


12,952



29,653


Long term receivables



8,755


5,388



9,713


Derivatives



2,679


2,635



2,972



494,441


467,291



548,555



Total assets



630,499


551,147



699,503



Liabilities and Equity



Current liabilities


Current maturities of long term bank loans



14,515


126,180



16,104


Current maturities of long term loans



16,401


16,401



18,196


Current maturities of debentures



19,785


19,806



21,950


Trade payables



3,080


2,904



3,416


Other payables



26,695


20,806



29,617


Current maturities of derivatives



34,030


14,783



37,754


Current maturities of lease liabilities



642


4,329



712



115,148


205,209



127,749



Non-current liabilities


Long-term lease liabilities



15,720


15,800



17,440


Long-term loans



222,627


39,093



246,993


Other long-term bank loans



38,355


37,221



42,553


Debentures



117,477


117,493



130,334


Deferred tax



6,244


8,836



6,927


Other long-term liabilities



3,793


3,905



4,208


Derivatives



41,915


10,107



46,502



446,131


232,455



494,957



Total liabilities



561,279


437,664



622,706



Equity


Share capital



25,605


25,605



28,407


Share premium



85,883


85,883



95,283


Treasury shares



(1,736)


(1,736)



(1,926)


Transaction reserve with non-controlling Interests



5,697


5,697



6,321


Reserves



(13,381)


7,288



(14,845)


Accumulated deficit



(10,151)


(7,217)



(11,262)


Total equity attributed to shareholders of




the Company



91,917


115,520



101,978


Non-Controlling Interest



(22,697)


(2,037)



(25,181)



Total equity



69,220


113,483



76,797



Total liabilities and equity



630,499


551,147



699,503


*


Convenience translation into US$ (exchange rate as at March 31, 20


2


2: euro 1 = US$


1.1


09)



Ellomay Capital Ltd. and its Subsidiaries



Condensed Consolidated Interim Statements of Comprehensive Loss




For the three months

ended March 31,





For the year ended

December 31,





For the three months

ended March 31,




2022



2021



2021



2022



Unaudited




Audited




Unaudited








in thousands








in thousands




Convenience

Translation into US$

in thousands*



Revenues



11,761


7,200


44,783



13,048


Operating expenses



(5,971)


(3,217)


(17,524)



(6,625)


Depreciation and amortization



(4,014)


(3,051)


(15,076)



(4,453)



Gross profit



1,776


932


12,183



1,970


Project development costs



(711)


(505)


(2,508)



(789)


General and administrative expenses



(1,477)


(1,263)


(5,661)



(1,639)


Share of profits of equity accounted investee



231


617


117



256



Operating profit (loss)



(181)


(219)


4,131



(202)


Financing income



809


912


2,931



898


Financing income (expenses) in connection with derivatives and warrants, net



(34)


(124)


(841)



(38)


Financing expenses in connection with projects finance



(1,365)


(1,434)


(17,800)



(1,514)


Financing expenses in connection with debentures



(1,029)


(1,101)


(3,220)



(1,142)


Interest expenses on minority shareholder loan



(543)


(382)


(2,055)



(602)


Other financing expenses



(784)


(637)


(5,899)



(870)



Financing expenses, net



(2,946)


(2,766)


(26,884)



(3,268)



Loss before taxes on income



(3,127)


(2,985)


(22,753)



(3,470)


Tax benefit (Taxes on income)



(279)


319


2,489



(310)



Loss for the period



(3,406)


(2,666)


(20,264)



(3,780)



Loss attributable to:


Owners of the Company



(2,934)


(2,069)


(15,408)



(3,255)


Non-controlling interests



(472)


(597)


(4,856)



(525)



Loss for the period



(3,406)


(2,666)


(20,264)



(3,780)



Other comprehensive income (loss) item



That after initial recognition in comprehensive income

(loss) were or will be transferred to profit or loss:


Foreign currency translation differences for foreign operations



(98)


562


12,284



(109)


Effective portion of change in fair value of cash flow hedges



(40,786)


(1,929)


(13,429)



(45,250)


Net change in fair value of cash flow hedges transferred to profit or loss



27


(1,004)


(3,353)



30



Total other comprehensive loss



(40,857)


(2,371)


(4,498)



(45,329)



Total other comprehensive loss attributable to:


Owners of the Company



(20,669)


(1,112)


3,124



(22,931)


Non-controlling interests



(20,188)


(1,259)


(7,622)



(22,398)



Total other comprehensive loss for the period



(40,857)


(2,371)


(4,498)



(45,329)



Total comprehensive


loss for the period



(44,263)


(5,037)


(24,762)



(49,109)



Total comprehensive loss attributable to:


Owners of the Company



(23,603)


(3,181)


(12,284)



(26,186)


Non-controlling interests



(20,660)


(1,856)


(12,478)



(22,923)



Total comprehensive


loss for the period



(44,263)


(5,037)


(24,762)



(49,109)



Basic net loss per share



(0.23)


(0.16)


(1.20)



(0.26)



Diluted net loss per share



(0.23)


(0.16)


(1.20)



(0.26)


Ellomay Capital Ltd. and its Subsidiaries



Condensed Consolidated Statements of Changes in Equity



Attributable to shareholders of the Company



Non- controlling



Total



Interests



Equity






Share capital






Share premium




Accumulated Deficit






Treasury shares




Translation reserve from



foreign operations






Hedging Reserve



Interests Transaction reserve with



non-controlling Interests






Total






in thousands



For the three months ended



March 31, 2022 (Unaudited):



Balance as at January 1, 2022



25,605



85,883



(7,217)



(1,736)



15,365



(8,077)



5,697



115,520



(2,037)



113,483



Loss for the period











(2,934)



















(2,934)



(472)



(3,406)



Other comprehensive loss for the period



















(90)



(20,579)







(20,669)



(20,188)



(40,857)



Total comprehensive loss for the period











(2,934)







(90)



(20,579)







(23,603)



(20,660)



(44,263)



Transactions with owners of the Company, recognized directly in equity:



Issuance of ordinary shares











































Acquisition of shares in subsidiaries from non-controlling interests



















Warrants exercise























Options exercise











































Share-based payments











































Balance as at March 31, 2022



25,605



85,883



(10,151)



(1,736)



15,275



(28,656)



5,697



91,917



(22,697)



69,220



For the three months



ended March 31, 2021 (Unaudited):



Balance as at January 1, 2021


25,102


82,401


8,191


(1,736)


3,823


341


6,106


124,228


798


125,026



Loss for the period






(2,069)










(2,069)


(597)


(2,666)



Other comprehensive income (loss) for the period










558


(1,670)




(1,112)


(1,259)


(2,371)



Total comprehensive income (loss) for the period






(2,069)




558


(1,670)




(3,181)


(1,856)


(5,037)



Transactions with owners of the Company, recognized directly in equity:



Buy of shares in subsidiaries from non-controlling interests














(961)


(961)


961





Warrants exercise


454


3,348












3,802




3,802



Options exercise


22














22




22



Share-based payments




7












7




7



Balance as at March 31, 2021


25,578


85,756


6,122


(1,736)


4,381


(1,329)


5,145


123,917


(97)


123,820


Ellomay Capital Ltd. and its Subsidiaries



Condensed Consolidated Interim Statements of Changes in Equity (cont’d)



Attributable to shareholders of the Company



Non- controlling



Total



Interests



Equity






Share capital






Share premium




Accumulated Deficit






Treasury shares




Translation reserve from



foreign operations






Hedging Reserve



Interests Transaction reserve with



non-controlling Interests






Total



€ in thousands



For the year ended



December 31, 2021 (Audited):



Balance as at January 1, 202

1


25,102


82,401


8,191


(1,736)


3,823


341


6,106


124,228


798


125,026



Profit (loss) for the year






(15,408)










(15,408)


(4,856)


(20,264)



Other comprehensive income (loss) for the

year










11,542


(8,418)




3,124


(7,622)


(4,498)



Total comprehensive income (loss) for the

year






(15,408)




11,542


(8,418)




(12,284)


(12,478)


(24,762)



Transactions with owners of the Company,

recognized directly in equity:



Issuance of ordinary shares


















8,682


8,682



Acquisition of shares in subsidiaries

from non-controlling interests


(409)


(409)


961


552



Warrants exercise


454


3,419


3,873




3,873



Options exercise


49














49




49



Share-based payments




63












63




63



Balance as at December 31, 202

1


25,605


85,883


(7,217)


(1,736)


15,365


(8,077)


5,697


115,520


(2,037)


113,483


Ellomay Capital Ltd. and its Subsidiaries


Condensed Consolidated Interim Statements of Changes in Equity (

cont’d

)



Attributable to shareholders of the Company



Non- controlling



Total



Interests



Equity






Share capital






Share premium




Retained earnings






Treasury shares




Translation reserve from



foreign operations






Hedging Reserve




Interests Transaction reserve with





non-controlling Interests







Total




Convenience translation into US$ (exchange rate as at March 3





1





, 2022: euro 1 = US$ 1.1





09





)





For the three-month ended March 31, 2022 (unaudited):





Balance as at January 1, 2022




28,407



95,283



(8,007)



(1,926)



17,047



(8,961)



6,321



128,164



(2,258)



125,906




Loss for the period












(3,255)



















(3,255)



(525)



(3,780)




Other comprehensive loss for the period




















(100)



(22,831)







(22,931)



(22,398)



(45,329)




Total comprehensive loss for the period












(3,255)







(100)



(22,831)







(26,186)



(22,923)



(49,109)




Transactions with owners of the Company, recognized directly in equity:





Buy of shares in subsidiaries from non-controlling interests













































Warrants exercise













































Options exercise













































Share-based payments













































Balance as at





March 31, 2022




28,407



95,283



(11,262)



(1,926)



16,947



(31,792)



6,321



101,978



(25,181)



76,797


Ellomay Capital Ltd. and its Subsidiaries



Condensed Consolidated Interim Statements of Cash Flow



For the three months

ended March 31,



For the year ended

December 31,



For the three months

ended March 31,



2022



2021



2021



2022



Unaudited



Audited



Unaudited



€ in thousands



Convenience Translation

into US$ i


n thousands*



Cash flows from operating activities


Loss for the period



(3,406)


(2,666)


(20,264)



(3,780)



Adjustments for

:


Financing expenses, net



2,946


2,766


26,884



3,268


Profit from settlement of derivatives contract






(407)


(407)






Depreciation and amortization



4,014


3,051


15,076



4,453


Share-based payment transactions






7


63






Share of profits of equity accounted investees



(231)


(617)


(117)



(256)


Payment of interest on loan from an equity accounted investee








859






Change in trade receivables and other receivables



(2,814)


(1,182)


(1,883)



(3,122)


Change in other assets



1,841


30


(545)



2,042


Change in receivables from concessions project



252


221


1,580



280


Change




in trade payables



(75)


(382)


154



(83)


Change in other payables



5,274


1,596


2,380



5,851


Tax benefit (Taxes on income)



279


(319)


(2,489)



310


Income taxes paid








(94)






Interest received



471


427


1,844



523


Interest paid



(404)


(1,206)


(7,801)



(448)



11,553


3,985


35,504



12,818


Net cash from operating activities



8,147


1,319


15,240



9,038



Cash flows from investing activities


Acquisition of fixed assets



(15,527)


(25,653)


(82,810)



(17,226)


Acquisition of subsidiary, net of cash acquire














VAT associated with the acquisition of fixed assets



(2,225)







(2,469)


Repayment of loan from an equity accounted investee








1,400






Loan to an equity accounted investee






(113)


(335)






Advances on account of investments














Proceeds from marketable securities














Acquisition of marketable securities














Proceeds from settlement of derivatives, net



(528)


(252)


(976)



(586)


Proceed (investment) in restricted cash, net



1,103


454


(5,990)



1,224


Investment in short term deposit






8,533


(18,599)






Proceeds (Investment) in Marketable Securities






1,785


(112)






Compensation as per agreement with Erez Electricity Ltd.















Net cash used in investing activities



(17,177)


(15,246)


(107,422)



(19,057)



Cash flows from financing activities


Issuance of warrants








3,746






Repayment of long-term loans and finance lease obligations



(121,372)


(457)


(18,905)



(134,656)


Repayment of SWAP instrument associated with long term loans



(3,290)







(3,650)


Repayment of Debentures






(21,877)


(30,730)






Cost associated with long term loans



(8,460)


(197)


(2,796)



(9,386)


Proceeds from options






22


49






Sale of shares in subsidiaries to non-controlling interests






1,400


1,400






Issuance of ordinary shares






3,675








Payment of principal of lease liabilities



(3,795)




(4,803)



(4,210)


Proceeds from long term loans, net



196,520


27,061


32,947



218,028


Proceeds from issue of convertible debentures






15,571


15,571






Proceeds from issuance of Debentures, net






25,465


57,717







Net cash from financing activities



59,603


50,663


54,196



66,126


Effect of exchange rate fluctuations on cash and cash equivalents



(821)


1,439


12,370



(910)


Increase (decrease) in cash and cash equivalents



49,752


38,175


(25,616)



55,197


Cash and cash equivalents at the beginning of the period



41,229


66,845


66,845



45,741



Cash and cash equivalents at the end of the period



90,981


105,020


41,229



100,938


* Convenience translation into US$ (exchange rate as at March 31, 2022: euro 1 = US$ 1.109)



Ellomay Capital Ltd. and its Subsidiaries


Operating Segments




PV





Total





Ellomay





Bio





reportable





Total





Italy





Spain





Solar

1





Talasol





Israel

2





Gas





Dorad





Manara





segments





Reconciliations





consolidated





For the three months ended March 31, 2022




€ in thousands



Revenues







852







7,501



926



3,138



14,516







26,933



(15,172)



11,761


Operating expenses







(160)







(3,069)



(105)



(2,637)



(10,646)







(16,617)



10,646



(5,971)


Depreciation expenses







(242)







(2,802)



(629)



(842)



(1,780)







(6,295)



2,281



(4,014)



Gross profit (loss)







450







1,630



192



(341)



2,090







4,021



(2,245)



1,776


Project development costs



(711)


General and


administrative expenses



(1,477)


Share of loss of equity



231


accounted investee



Operating profit



(181)


Financing income



809


Financing


expenses


in connection


with derivatives




and warrants, net



(34)


Financing expenses in connection with projects finance



(1,365)


Financing expenses in connection with debentures



(1,029)


Interest expenses on minority shareholder loan



(543)


Other financing expenses



(784)


Financing expenses, net



(2,946)



Loss before taxes



on Income



(3,127)



Segment assets as at



March 31, 2022



2,130



14,278



17,891



301,701



38,333



33,813



117,980



126,731



652,857



(22,358)



630,499


Ellomay


Capital Ltd. and its Subsidiaries


Reconciliation of Loss to EBITDA




For the three

months ended

March 31,





For the year

ended December

31,





For the three

months ended

March 31,




2022



2021



2021



2022




Unaudited










in thousands





Convenience Translation into US$




in thousands*



Net loss for the period



(3,406)


(2,666)


(20,264)



(3,780)


Financing expenses, net



2,946


2,766


26,884



3,268


Taxes on income (Tax benefit)



279


(319)


(2,489)



310


Depreciation



4,014


3,051


15,076



4,453


EBITDA



3,833


2,832


19,207



4,251


* Convenience translation into US$ (exchange rate as at March 31, 2022: euro 1 = US$ 1.109)

Ellomay Capital Ltd.

Information for the Company’s Debenture Holders

Pursuant to the Deeds of Trust governing the Company’s Series C and Series D Debentures (together, the ”

Debentures

“), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on

March 31, 2022

and below.


Net Financial Debt

As of

March 31, 2022

, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €18.3 million (consisting of approximately €295.8

3

million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €139.5

4

million in connection with the Series C Debentures issuances (in

July 2019

,

October 2020

,

February 2021

and

October 2021

) and Series D Debentures issuance (in

February 2021

), net of approximately €121.2 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €295.8

5

million of project finance and related hedging transactions of the Company’s subsidiaries).


Information for the Company’s Series C Debenture Holders.

The Deed of Trust governing the Company’s Series C Debentures (as amended on

June 6, 2022

, the ”

Series C Deed of Trust

“), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of

March 31, 2022

, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series C Deed of Trust) was approximately €126.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 12.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA

6

, was 0.8.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended

March 31, 2022

:


For the four-quarter period

ended March 31, 2022



Unaudited






in thousands


Loss for the period



(21,004)


Financing expenses, net



27,064


Tax benefit



(1,891)


Depreciation



16,039


Adjustment to revenues of the Talmei Yosef PV Plant due to

calculation based on the fixed asset model



3,292


Share-based payments



42


Adjusted EBITDA as defined the Series C Deed of Trust



23,542


Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of

March 31, 2022

, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €126.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 12.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA

7

was 0.8.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended

March 31

, 2022:


For the four quarter period

ended March 31, 2022



Unaudited






in thousands


Loss for the period



(21,004)


Financing expenses, net



27,064


Taxes on income



(1,891)


Depreciation



16,039


Adjustment to revenues of the Talmei Yosef PV Plant due to

calculation based on the fixed asset model



3,292


Share-based payments



42


Adjusted EBITDA as defined the Series D Deed of Trust



23,542


1

Ellomay Solar S.L, the owner of a 28 MW photovoltaic facility near the Talasol PV Plant.


2

The Talmei Yosef PV Plant located in

Israel

is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.


3

Short-term and long-term debt from banks and other interest bearing financial obligations amount provided above, includes an amount of approximately €0.4 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.


4

Debentures amount provided above includes an amount of approximately €2.3 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company’s balance sheet.


5

The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).


6

The term “Adjusted EBITDA” is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”


7

The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

Cision
View original content:

https://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-three-months-ended-march-31-2022-301578280.html

SOURCE Ellomay Capital Ltd.